12:00 AM
Nov 16, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Seroquel quetiapine: Post-marketing study data

Data from the post-marketing SATIETY trial in 338 patients ages 4-19 showed that first-time use of 4 second-generation antipsychotic drugs - olanzapine, quetiapine, risperidone and aripiprazole - was associated with significant weight gain from baseline compared with no treatment. Specifically, after a median of 10.8 weeks of treatment, weight increased by 8.5, 6.1, 5.3 and 4.4 kg...

Read the full 262 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >